Webinar Organizers:
Cervical glandular lesion management is a challenge for clinicians from screening to diagnosis and treatment. This webinar will discuss the contents from screening to colposcopy, pathology and treatment.
Objectives:
Participants will learn the difficulties of cervical glandular lesions in cytology and histology, the management of AGC, the colposcopy image of AIS, and the management AIS.
Program:
Faculty:
Chengquan Zhao, MD; Professor of gynecological/breast pathology and cytological director of Magee Womens Hosptial, University of Pittsburgh Dr. Zhao received Medicine degree from Qingdao Medical College, China, completed four years residency training in Pathology at Drexel University, one year fellow training in Gynecologic/Breast Pathology at AFIP, and one year fellow training in Cytopathology at the University of Southern California. He joined the faculty of the Department of Pathology, Magee Women Hospital in July 2006 and promoted as full professor at 2012. His research interests are focused on the areas of cervical cancer screening, correlation of Pap test and HPV test. He has published 230 papers and 160 abstracts.
Long Sui, MD, PhD; Obstetrics & Gynecology Hospital, Fudan University; Professor and Chief Physician for Gynecology, Gynecologic Oncology, Colposcopy and Gynecologic Endoscopy Prof and Dr. Long Sui is an expert of the Committee on Continuing Education and Training, IFCPC and Vice chairman of both the Chinese Society of Colposcopy and Cervical Pathology, CSCCP and the Chinese Obstetrics And Gynecology Association Colposcopy and Cervical Neoplasia Committee, COGA-CCNC. He has led or participated in the drafting of several practice guidelines or expert consensus on the prevention and treatment of CIN, VaIN, VIN, AIN and HPV vaccine in China. He has hosted 14 research projects funded by the National Natural Science Foundation and et al and published over 160 papers in peer reviewed core journals. Achieved 4 scientific and technological progress awards.
Yun Zhao, MD, PhD; Peking University People’s Hospital Dr ZHAO Yun is a staff physician in the department of Obstetrics/Gynecology at Peking University People’s Hospital. She got MD from Chinese PLA Postgraduate Medical School in 1999. She got Ph.D from Peking University Health Science Center in 2002. Dr. ZHAO specializes in the prevention, diagnosis and treatment of lower genital tract disease. Her clinical interests include cytology, colposcopy and precancer treatment. In 2012, she came to USA as oversea visitor, work in the Pathology and Laboratory Medicine Institute, Department of Anatomy Pathology, and in the Obgyn and Women’s Health Institute, Department of Gynecology. Cleveland Clinic. She has been working in Department of Obstetrics/Gynecology for more than 30 years.
Chair:
Jean-Luc Mergui, MD; France President, The International Federation of Cervical Pathology and Colposcopy (IFCPC)
This webinar will discuss the rationale behind updating the guidelines for cervical cancer screening in immunosuppressed women. We will delve into the methodological approach used to revise the guidelines and the key factors that necessitated the update. Next, we will present an overview of the latest evidence supporting the updated guidelines, highlighting the research studies, clinical trials, and case series that have informed the changes in cervical cancer screening recommendations for immunosuppressed women. This section will also focus on the implications of these findings for clinical practice. Finally, we will summarize the key conclusions drawn from the updated guidelines and their impact on the management of cervical cancer screening in immunosuppressed women with an emphasis on the importance of adhering to these recommendations to improve patient outcomes and reduce the burden of cervical cancer in this vulnerable population.
Lisa Flowers, MD, MPH; Professor in the Department of Obstetrics and Gynecology, Emory University School of Medicine; Atlanta, Georgia, USA
Dr. Lisa Flowers is a Professor in the Department of Obstetrics and Gynecology, Fellowship Director of the Lower Anogenital Screening and Treatment Fellowship, Director of the Colposcopy and Anoscopy clinics at Emory University Healthcare Systems and partners. She is a gynecologist specializing in HPV related cancers and health disparities especially in HIV populations. She has been a clinical specialist and translational researcher in the screening, detection and treatment of HPV related precancers and cancer. She is the Emory PI for the NCI Cervical Cancer ‘Last Mile’ Initiative, Self-collection for HPV testing to Improve Cervical Cancer Prevention (SHIP) Trial and the Emory PI for the NCI’s HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network, a cooperative agreement-funded program focused on pragmatic clinical trials to optimize the cervical cancer screening, management, and precancer treatment cascade for women living with HIV. She is also the Emory site Principal Investigator (PI) for the AIDS Malignancy Consortium (AMC) and site PI for the NIH/NCI multi-site study ANCHOR focusing on HPV related precancerous cells in women and men with HIV. She was awarded an R01 on oral microbiome and periodontal diseases in oral HPV infection among people living with HIV, R01 on screening strategies and social determinants of health among people with high risk of anal cancer and a U01 addressing community home-based education, screening services; strategy to increase cervical cancer control access for HIV positive women in Nigeria. Dr. Flowers is the Co-chair of the International Anal Neoplasia Society working group for implementation and dissemination of the newly developed anal cancer screening guidelines. She has over 26 years of experience in specializing in colposcopy in persons living with HPV related disease in both clinical and research settings.
Michael A. Gold, MD; Clinical Associate Professor in the Department of Obstetrics and Gynecology at University of Oklahoma School of Community Medicine; Tulsa, Oklahoma, USA
Dr. Gold, is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at the University of Oklahoma School of Community Medicine. Dr. Gold specializes in gynecologic oncology and pelvic surgery. Dr. Gold received his medical degree from Jefferson Medical College in Philadelphia, PA. He completed his residency in gynecology and obstetrics at Thomas Jefferson University Hospital, also in Philadelphia. After residency, Dr. Gold completed his three-year fellowship in gynecologic oncology at the University of Oklahoma Health Sciences Center in Oklahoma City, where he remained on the faculty for nine years. He then moved to Vanderbilt University Medical Center, where he was the Director of the Division of Gynecologic Oncology. Dr. Gold’s clinical interests include the prevention and treatment of cervical cancer and pre-cancer (dysplasia) of the cervix, vagina, and vulva. He is active in clinical research focusing on gynecologic cancers in general and the imaging of cervical and uterine cancer, in particular. Dr. Gold is board certified by the American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology. Dr. Gold is a Fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons. He is an active member of the Gynecologic Oncology Group, the Society of Gynecologic Oncologists, the American Society of Colposcopy and Cervical Pathology, and the American College of Radiology Imaging Network.
Barbara Moscicki, MD; Professor of Pediatrics at UCLA; Los Angeles, California, USA
Barbara Moscicki is Professor of Pediatrics at UCLA, Division Chief of Adolescent and Young Adult Medicine, and Associate Vice Chair of Clinical Research, Department of Pediatrics. Dr. Moscicki is Past President for the ASCCP. Dr. Moscicki’s career has focused on adolescent gynecology and sexually transmitted infection research with a specific focus in Human Papillomavirus, HIV infection and mucosal immunology. Dr. Moscicki has been the principle investigator of a natural history study of HPV in adolescents and young women since 1990, one of the longest running HPV cohorts. Her work was highly influential in forming the new cervical cancer screening guidelines and triage of abnormal cytology in young women. Her recent work focuses on mucosal immunology and the vaginal microbiota. She has been involved in numerous clinical trials including vaginal microbiocides and an ongoing one dose HPV vaccine trial. She is also involved in health outcomes in perinatally HIV infected children including HPV vaccine efficacy, sexual risk behaviors, substance use, oral health, microbiomes, and HPV infections and has worked with numerous Networks on HIV disease in children and adolescents including Adolescent Medicine HIV/AIDS Research Network, Adolescent Therapeutic Network, IMPAACT and PHACS. She has over 150 publications and she serves on numerous national and international committees, including the W.H.O., N.I.H., ASCCP, and the American Cancer Society.
Jean-Luc Mergui, MD; France; President, The International Federation of Cervical Pathology and Colposcopy (IFCPC)
Registration:
Notes:
PDF Flyer
Human papillomavirus (HPV) is one of the most common viral etiologies of sexually transmitted genital infections in sexually active women. In the genital area during pregnancy, genital warts or low- and high-grade intraepithelial lesions occur, as well as a lower incidence of malignant neoplasia. Diseases associated with HPV infection during pregnancy should be documented and treated according to guidelines and evidence, when detected, to reduce the risk of transmission to the newborn.
Janeth Márquez Acosta
Elsa Díaz López
Guillermo Moreno
Janeth Márquez Acosta, MD, OBGYN, MHA Dr. Janeth is a respected Professor of Obstetrics & Gynecology at the Faculty of Medicine, UNAM, and a dedicated practitioner at the High Specialty Medical Unit “Luis Castelazo Ayala Hospital” under the Mexican Social Security Institute. She specializes in colposcopy within the Department of Colposcopy and is an esteemed member of COMEGIC (Mexican college of gynecologists dedicated to colposcopy).
Elsa Díaz López, MD, MBE Dr. Elsa Diaz Lopez is an accomplished Obstetrician and Gynecologist with a Master's in Bioethics and teaching techniques in health sciences. She serves as the 1st Secretary of COMEGO (Mexican College of Obstetrics and Gynecology) and Secretary General of IFCPC (International Federation of Cervical Pathology and Colposcopy). Her extensive research includes publications on HPV vaccination in vulnerable populations, contributions to the Mexican Cancer Consensus, and guidelines for adult vaccinations.
Guillermo Moreno Flores, MD, MSc Dr. Guillermo is a highly qualified specialist in Gynecology and Obstetrics, having trained at the National Institute of Perinatology in Mexico. He holds certifications in colposcopy, laparoscopy, and an advanced specialty in breast cancer diagnosis and treatment. With a subspecialty in Gynecologic Oncology from the National Cancer Institute, Mexico, and a Master's degree in medical sciences, Dr. Guillermo has contributed to numerous national and international publications in indexed journals. He is also an active member of prestigious organizations like ESGO, IGCS, IFCPC, and COMEGIC.
Marta del Pino
Marta del Pino, MD, PhD; Consultant, Hospital Clinic; Barcelona, SpainDr. Marta del Pino is a consultant in the Gynecologic Oncology Unit at Hospital Clínic de Barcelona and an Associate Professor at the University of Barcelona. She holds a Master’s in Statistics and Epidemiology with a focus on Health Sciences. Her career has been dedicated to HPV-related cancers, particularly those affecting the lower genital tract. Following her postdoctoral research on HPV at the Vrije Universiteit Medisch Centrum in Amsterdam, she has led numerous national and international research projects on HPV vaccination, screening strategies, and biomarkers for early detection and progression of HPV-associated lesions. Dr. del Pino has played a leading role in anal cancer screening initiatives in women, especially those with genital HPV-related disease. She also contributed to Spain’s 2024 National Cervical Cancer Screening Guidelines and to the implementation of Catalonia’s population-based screening program.
Adrià Curran, MD, PhD; Hospital Vall d’Hebron; Barcelona, SpainDr. Adrià Curran Fàbregas is a specialist in Internal Medicine at the Hospital Universitari Vall d’Hebron in Barcelona, where he has worked in the Infectious Diseases Department since 2005. He holds a Master’s in Clinical Research. His clinical and research focus lies in HIV infection, sexually transmitted infections (STIs), and human papillomavirus (HPV). Since 2012, he has been part of the Anal Dysplasia Screening Unit and is an active investigator in national and international clinical trials related with infectious diseases.
José Luis Blanco, MD, PhD; Consultant ID. Hospital Clinic; Barcelona, SpainJose Luis Blanco Arévalo. MD. PhD. ID Consultant. Associated Professor University of Barcelona (since 2005). Professor del Master of AIDS University of Barcelona (since 2002). Consultant in charge (since 2010), Sexually Transmission Diseases Unit and Program of Anal Canal Cancer Prevention Program, Medicine Department, Hospital Clinic, Barcelona, Spain. Member of the “International Anal Neoplasia Society” (IANS).
International Federation for Cancer Prevention and Colposcopy 3416 Primm Lane Birmingham, Alabama, 35216 USA P: +001-205-823-6106 E: info@ifcpc.org
